Lorem Cytori Usa, Inc

Lorem Cytori Usa, Inc company information, Employees & Contact Information

Lorem Cytori is a specialty therapeutics company focused on addressing significant unmet medical and market needs with cell therapy platforms. Cytori Cell Therapy for scleroderma associated hand dysfunction, prepared using the Celution instrument and consumable set, is one of Cytori’s lead product candidates. Cytori Cell Therapy is also being studied for thermal burns, hip osteonecrosis, knee osteoarthritis, and stress urinary incontinence in the US and Japan.

Company Details

Employees
42
Founded
-
Address
3020 Callan Road, San Diego,ca 92121,united States
Phone
+1.858.458.0900
Email
cu****@****ori.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Website
cytori.com
HQ
San Diego, CA
Looking for a particular Lorem Cytori Usa, Inc employee's phone or email?

Lorem Cytori Usa, Inc Questions

News

Cytori Completes Enrollment for Habeo™ Cell Therapy for Scleroderma & Impaired Hand Function - BioInformant

Cytori Completes Enrollment for Habeo™ Cell Therapy for Scleroderma & Impaired Hand Function BioInformant

Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program - GlobeNewswire

Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program GlobeNewswire

Analysts Expect Breakeven For Cytori Therapeutics, Inc. (NASDAQ:CYTX) - Yahoo Finance

Analysts Expect Breakeven For Cytori Therapeutics, Inc. (NASDAQ:CYTX) Yahoo Finance

Cytori launches next-gen Celution cell therapy tech - Drug Delivery Business

Cytori launches next-gen Celution cell therapy tech Drug Delivery Business

Cytori hooks Azaya, acquires delivery platform - BioPharma Dive

Cytori hooks Azaya, acquires delivery platform BioPharma Dive

Phase 3 STAR Trial of Cytori’s Cell Therapy Completes 48-Week Follow-up Visits - raynaudsnews.com

Phase 3 STAR Trial of Cytori’s Cell Therapy Completes 48-Week Follow-up Visits raynaudsnews.com

Cytori to Acquire Azaya Platform, Cancer Candidates - Genetic Engineering and Biotechnology News

Cytori to Acquire Azaya Platform, Cancer Candidates Genetic Engineering and Biotechnology News

Cytori appoints CEO of Cerium Pharmaceuticals to board - Reuters

Cytori appoints CEO of Cerium Pharmaceuticals to board Reuters

Cytori Shares Surge On Up To $531 Mln Licensing Deal With Lorem Vascular - RTTNews

Cytori Shares Surge On Up To $531 Mln Licensing Deal With Lorem Vascular RTTNews

Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient - Lung Disease News

Cytori Updates Phase 3 Scleroderma STAR Trial, Enrolls 60th Patient Lung Disease News

Cytori Forms Stem Cell Therapy Distribution Partnership with MBA Grupo - Technology Networks

Cytori Forms Stem Cell Therapy Distribution Partnership with MBA Grupo Technology Networks

Cytori, Lorem Vascular To Commercialize Cell-Based Therapies - Asian Scientist Magazine

Cytori, Lorem Vascular To Commercialize Cell-Based Therapies Asian Scientist Magazine

A Conversation With Christopher J. Calhoun, CEO of Cytori Therapeutics - The Atlantic

A Conversation With Christopher J. Calhoun, CEO of Cytori Therapeutics The Atlantic

Japan, Saudi medical centers unite to revolutionize stem cell therapy - arabnews.jp

Japan, Saudi medical centers unite to revolutionize stem cell therapy arabnews.jp

Cytori Therapeutics Inc. (CYTX) Tumbles in Pre-market Hours After Pricing Public Offering - Insider Monkey

Cytori Therapeutics Inc. (CYTX) Tumbles in Pre-market Hours After Pricing Public Offering Insider Monkey

Cytori Will Become Plus Therapeutics, Inc. - GlobeNewswire

Cytori Will Become Plus Therapeutics, Inc. GlobeNewswire

Azaya Therapeutics and its nanoparticle cancer drugs acquired by Cytori - Drug Delivery Business

Azaya Therapeutics and its nanoparticle cancer drugs acquired by Cytori Drug Delivery Business

Lorem Vascular Licenses Cytori Cell Therapy for Asia-Pacific in Up to $531M Deal - Genetic Engineering and Biotechnology News

Lorem Vascular Licenses Cytori Cell Therapy for Asia-Pacific in Up to $531M Deal Genetic Engineering and Biotechnology News

Promising Scleroderma Clinical Trial May Improve Hand Dysfunction - Lung Disease News

Promising Scleroderma Clinical Trial May Improve Hand Dysfunction Lung Disease News

Cytori Wins Up to $106M Biodefense Cell Therapy Contract - Genetic Engineering and Biotechnology News

Cytori Wins Up to $106M Biodefense Cell Therapy Contract Genetic Engineering and Biotechnology News

Cytori CEO Calhoun retires - San Diego Union-Tribune

Cytori CEO Calhoun retires San Diego Union-Tribune

Top Lorem Cytori Usa, Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant